Citigroup’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Citigroup’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,000	Closed	-$1.04M	–	6201
2025 Q3	$1.04M	Buy	+30,000	New	+$960K	﹤0.01%	3139
2024 Q2	–	Sell	-30,000	Closed	-$966K	–	5656
2024 Q1	$966K	Hold	30,000	–	–	﹤0.01%	3054
2023 Q4	$1.22M	Buy	+30,000	New	+$1.1M	﹤0.01%	2660

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

denkapparat Operations Berlin, Germany $379M AUM 28.36% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

MQS Management New York $171M AUM 3.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Citigroup's LKFT Position: Q3 2026 in Review

Citigroup increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 12% in Q3 2026, buying an estimated $1.18K and bringing the position to 395 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5145.

Citigroup first reported a position in LKFT in Q3 2015 and has held it in 35 quarters since. The position peaked at $20.6M in Q2 2020. 33 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

Citigroup held 395 shares of Lakefront Biotherapeutics American Depositary Shares worth $11.7K as of Q3 2026.
Citigroup bought 41 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $1.18K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5145 holding.
Citigroup first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 35 quarters since.
Citigroup's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.6M in Q2 2020.
33 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.